Replies to post #129861 on Biotech Values

[y3maxx]

""Difference being, with IP protection, the market may give MNTA a larger multiple. Say 5-10x vs. 2x that we currently enjoy.

Which either way you look at it, pretty much, you get copaxone and FoB for free. But we already knew that.""

Tinker

...Difference being, with IP protection, How about 5-10-20 or -30 X's vs current 2 X's?

...After @ a year and a half is it finally Long's turn?

best wishes to us L's tomorrow

y3